Research Supporting Integrative Cancer Care
This message contains search results from the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).
Search: use of TCM in Cancer treatment OR cancer recovery
Filters: in the last 5 years, Free full text
20 selected items
Items 1-20 of 20 (Display the 20 citations in PubMed)
|
1.
|
Shang L, Wang Y, Li J, Zhou F, Xiao K, Liu Y, Zhang M, Wang S, Yang S. J Ethnopharmacol. 2023 Feb 10;302(Pt A):115876. doi: 10.1016/j.jep.2022.115876. Epub 2022 Nov 5. PMID: 36343798 |
|
2.
|
Zou B, Long Y, Gao R, Liu Q, Tian X, Liu B, Zhou Q. Phytomedicine. 2024 Dec;135:155554. doi: 10.1016/j.phymed.2024.155554. Epub 2024 Mar 29. PMID: 39341127 Review. |
|
3.
|
Liu Y, Huang T, Wang L, Wang Y, Liu Y, Bai J, Wen X, Li Y, Long K, Zhang H. J Ethnopharmacol. 2025 Jan 30;337(Pt 1):118812. doi: 10.1016/j.jep.2024.118812. Epub 2024 Sep 10. PMID: 39260710 Review. |
|
4.
|
Traditional Chinese medicine in lung cancer treatment. Xi Z, Dai R, Ze Y, Jiang X, Liu M, Xu H. Mol Cancer. 2025 Feb 26;24(1):57. doi: 10.1186/s12943-025-02245-6. PMID: 40001110 Free PMC article. Review. |
|
5.
|
Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches. Liu F, Chen J, Li K, Li H, Zhu Y, Zhai Y, Lu B, Fan Y, Liu Z, Chen X, Jia X, Dong Z, Liu K. Mol Cancer. 2024 Jul 25;23(1):148. doi: 10.1186/s12943-024-02046-3. PMID: 39048965 Free PMC article. Review. |
|
6.
|
The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers. Tang Q, Chen Y, Li X, Long S, Shi Y, Yu Y, Wu W, Han L, Wang S. Front Immunol. 2022 Sep 13;13:964442. doi: 10.3389/fimmu.2022.964442. eCollection 2022. PMID: 36177034 Free PMC article. Review. |
|
7.
|
Traditional Chinese medicine in the treatment of breast Cancer. Song P, Liu T, Zhang Y, Shao T, Li R, An C, Cao LQ, Chen ZS, Guo W, Duan D. Mol Cancer. 2025 Aug 1;24(1):209. doi: 10.1186/s12943-025-02416-5. PMID: 40750898 Free PMC article. Review. |
|
8.
|
Discovery and repurposing of artemisinin. Shi Q, Xia F, Wang Q, Liao F, Guo Q, Xu C, Wang J. Front Med. 2022 Feb;16(1):1-9. doi: 10.1007/s11684-021-0898-6. Epub 2022 Mar 15. PMID: 35290595 Free PMC article. Review. |
|
9.
|
Shao G, Liu Y, Lu L, Wang L, Ji G, Xu H. J Ethnopharmacol. 2024 Jun 12;327:117999. doi: 10.1016/j.jep.2024.117999. Epub 2024 Mar 4. PMID: 38447616 Review. |
|
10.
|
Tailoring traditional Chinese medicine in cancer therapy. Li S, Chen X, Shi H, Yi M, Xiong B, Li T. Mol Cancer. 2025 Jan 21;24(1):27. doi: 10.1186/s12943-024-02213-6. PMID: 39838407 Free PMC article. Review. |
|
11.
|
Wu J, Tang G, Cheng CS, Yeerken R, Chan YT, Fu Z, Zheng YC, Feng Y, Wang N. Mol Cancer. 2024 Oct 1;23(1):218. doi: 10.1186/s12943-024-02136-2. PMID: 39354529 Free PMC article. Review. |
|
12.
|
Diagnostic, Prognostic, and Immunological Roles of HELLS in Pan-Cancer: A Bioinformatics Analysis. Liang X, Li L, Fan Y. Front Immunol. 2022 Jun 14;13:870726. doi: 10.3389/fimmu.2022.870726. eCollection 2022. PMID: 35774795 Free PMC article. |
|
13.
|
Zhang J, Qin Z, So TH, Chang TY, Yang S, Chen H, Yeung WF, Chung KF, Chan PY, Huang Y, Xu S, Chiang CY, Lao L, Zhang ZJ. Breast Cancer Res. 2023 Apr 26;25(1):49. doi: 10.1186/s13058-023-01645-0. PMID: 37101228 Free PMC article. Clinical Trial. |
|
14.
|
Shi X, Wang X, Yao W, Shi D, Shao X, Lu Z, Chai Y, Song J, Tang W, Wang X. Signal Transduct Target Ther. 2024 Aug 2;9(1):192. doi: 10.1038/s41392-024-01885-2. PMID: 39090094 Free PMC article. Review. |
|
15.
|
Cellular senescence and SASP in tumor progression and therapeutic opportunities. Dong Z, Luo Y, Yuan Z, Tian Y, Jin T, Xu F. Mol Cancer. 2024 Aug 31;23(1):181. doi: 10.1186/s12943-024-02096-7. PMID: 39217404 Free PMC article. Review. |
|
16.
|
Traditional Chinese medicine for breast cancer treatment: a bibliometric and visualization analysis. Yuan J, Liu Y, Zhang T, Zheng C, Ding X, Zhu C, Shi J, Jing Y. Pharm Biol. 2024 Dec;62(1):499-512. doi: 10.1080/13880209.2024.2359105. Epub 2024 May 30. PMID: 38813803 Free PMC article. Review. |
|
17.
|
The positive role of traditional Chinese medicine as an adjunctive therapy for cancer. Zhang X, Qiu H, Li C, Cai P, Qi F. Biosci Trends. 2021 Nov 21;15(5):283-298. doi: 10.5582/bst.2021.01318. Epub 2021 Aug 20. PMID: 34421064 Review. |
|
18.
|
Effects of TCM on polycystic ovary syndrome and its cellular endocrine mechanism. Chen H, Deng C, Meng Z, Meng S. Front Endocrinol (Lausanne). 2023 May 16;14:956772. doi: 10.3389/fendo.2023.956772. eCollection 2023. PMID: 37260441 Free PMC article. Review. |
|
19.
|
Traditional Chinese medicine and lung cancer–From theory to practice. Li Z, Feiyue Z, Gaofeng L. Biomed Pharmacother. 2021 May;137:111381. doi: 10.1016/j.biopha.2021.111381. Epub 2021 Feb 15. PMID: 33601147 Review. |
|
20.
|
Traditional Chinese medicine for precancerous lesions of gastric cancer: A review. Xu W, Li B, Xu M, Yang T, Hao X. Biomed Pharmacother. 2022 Feb;146:112542. doi: 10.1016/j.biopha.2021.112542. Epub 2021 Dec 20. PMID: 34929576 Review. |